ACOG recently issued guidance recommending for the first time that clinicians consider concurrent male sex partner therapy ...

Bacterial vaginosis (BV) affects about one-quarter of reproductive-age women and is linked to adverse health outcomes, such as increased HIV risk. Yet for decades, BV treatment in the United States ...

First New Oral Treatment for Bacterial Vaginosis in a Decade - SAN ANTONIO, May 24 /PRNewswire/ -- Mission Pharmacal today announced that the U.S. Food and Drug Administration (FDA) approved ...

Add Yahoo as a preferred source to see more of our stories on Google. For some women, bacterial vaginosis, or BV, is such a common occurrence that they find themselves regularly dealing with the ...

One in three women are affected by bacterial vaginosis (BV), a common but poorly understood condition caused by an imbalance of vaginal bacteria that can cause discomfort and pain. BV is treated with ...

Despite numerous therapeutic research efforts, treatment of BV remains cumbersome and clinicians are currently rather poorly armed to treat BV properly in the long run. Moreover, appraisal of the ...

Bacterial vaginosis (BV) is a common vaginal infection affecting nearly 1 in 3 females globally with strong recurrence rates. While the emphasis on treatment has focused on females, a new study ...

Treating male sexual partners and women with bacterial vaginosis was better than treating women alone. Unlike past trials, both oral and topical antibiotic partner treatment was key. Adherence from ...

Have you ever felt embarrassed or worried after noticing a fishy smell in your genital area? If you’re a woman, that smell usually indicates bacterial vaginosis (BV) and can be treated with ...